Patents by Inventor Dominique N. Markowski

Dominique N. Markowski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • p19Arf, HMGA2 and MDM2 For Use in the Diagnosis and Treatment of Aberrant Cell Growth
    Publication number: 20140371237
    Abstract: Provided are novel methods and compositions for the diagnosis, prognosis and treatment of leiomyomas, in particular uterine leiomyoma (UL). In addition, methods of identifying anti-tumor agents are described. Furthermore, novel methods and compositions are provided for the treatment of diseases characterized by an aberrant growth of mesenchymal stem cells and their descendants and for the treatment of obesity are disclosed.
    Type: Application
    Filed: August 6, 2014
    Publication date: December 18, 2014
    Inventors: Jörn Bullerdiek, Dominique N. Markowski
  • WNT4 AND MED12 FOR USE IN THE DIAGNOSIS AND TREATMENT OF TUMOR DISEASES
    Publication number: 20140248294
    Abstract: Provided are novel methods and compositions for the diagnosis, prognosis and treatment of gynecological tumors, in particular uterine leiomyoma (UL). Furthermore, novel methods and compositions for the treatment of diseases characterized by an aberrant growth of mesenchymal stem cells and their descendants and for the treatment of pituitary and prostate tumors are described.
    Type: Application
    Filed: October 5, 2012
    Publication date: September 4, 2014
    Applicant: UNIVERSITY OF BREMEN
    Inventors: Jörn Bullerdiek, Dominique N. Markowski
  • p19Arf, HMGA2 and MDM2 For Use in the Diagnosis and Treatment of Aberrant Cell Growth
    Publication number: 20130149314
    Abstract: Provided are novel methods and compositions for the diagnosis, prognosis and treatment of leiomyomas, in particular uterine leiomyoma (UL). In addition, methods of identifying anti-tumor agents are described. Furthermore, novel methods and compositions are provided for the treatment of diseases characterized by an aberrant growth of mesenchymal stem cells and their descendants and for the treatment of obesity are disclosed.
    Type: Application
    Filed: February 9, 2011
    Publication date: June 13, 2013
    Inventors: Jörn Bullerdiek, Dominique N. Markowski